Dr. Lal PathLabs Limited
LALPATHLAB
주식 순위
#4512
Dr. Lal PathLabs Limited is a leading provider of diagnostic and related health... Dr. Lal PathLabs Limited is a leading provider of diagnostic and related health assessment services, operating both domestically in India and across international borders. The company manages a comprehensive network of laboratories dedicated to conducting pathological investigations across various specialized fields. These include biochemistry, hematology, histopathology, microbiology, electrophoresis, immunochemistry, immunology, virology, cytology, in addition to other general pathological and radiological studies. Beyond its core testing operations, Dr. Lal PathLabs also offers laboratory staff training, technical support, and full-scale lab management services. As of March 31, 2022, its widespread infrastructure included 277 clinical laboratories, notably a National Reference Lab located in Delhi and a Regional Reference Lab in Kolkata. This is further bolstered by 4,731 patient service centers and 10,599 sample collection points. Founded in 1949, Dr. Lal PathLabs Limited maintains its corporate base in Gurugram, India.
주가
$20.35
마지막 동기화: 2026-10-19
시가총액
$3.40B
변동 (1일)
-0.86%
변동 (1년)
13.63%
국가
IN
거래 Dr. Lal PathLabs Limited (LALPATHLAB)
카테고리
Healthcare
Dr. Lal PathLabs Limited (LALPATHLAB)의 발행 주식 수
June 2026 기준 발행 주식 수: 167.00M
Dr. Lal PathLabs Limited의 최신 재무 보고서와 주가에 따르면 현재 발행 주식 수는 167.00M입니다. March 2024 말 기준 회사는 166.47M주를 발행했습니다. 발행 주식 수는 일반적으로 주식 분할이나 자사주 매입에 의해 영향을 받습니다.
Dr. Lal PathLabs Limited (LALPATHLAB)의 발행 주식 수 기록 (2011 ~ 2026)
매년 말 기준 발행 주식 수
| 연도 | 발행 주식 수 | 변화 |
|---|---|---|
| 2026 (TTM) | 167.00M | 0.10% |
| 2025 | 166.83M | 0.22% |
| 2024 | 166.47M | 0.15% |
| 2023 | 166.21M | 0.19% |
| 2022 | 165.90M | 0.27% |
| 2021 | 165.46M | 0.22% |
| 2020 | 165.10M | 0.09% |
| 2019 | 164.95M | 0.58% |
| 2018 | 164.01M | 0.52% |
| 2017 | 163.15M | -1.38% |
| 2016 | 165.44M | 0.73% |
| 2015 | 164.24M | 0.00% |
| 2014 | 164.24M | 6.99% |
| 2013 | 153.51M | -7.13% |
| 2012 | 165.29M | 0.00% |
| 2011 | 165.29M | 0.00% |
유사 기업 또는 경쟁사의 발행 주식 수
| 회사 | 발행 주식 수 | 차이 | 국가 |
|---|---|---|---|
| 371.00M | 122.16% |
US
|
|
| 705.30M | 322.35% |
US
|
|
| 143.28M | -14.20% |
US
|
|
| - | - |
CN
|
|
| 282.00M | 68.87% |
US
|
